Cornea Research Foundation of America, Indianapolis, IN 46260, USA.
Cornea. 2010 May;29(5):523-7. doi: 10.1097/ICO.0b013e3181c11e5d.
To assess the effect of incision width (5.0 and 3.2 mm) on graft survival and endothelial cell loss 6 months and 1 year after Descemet stripping automated endothelial keratoplasty (DSAEK).
One hundred sixty-seven subjects with endothelial decompensation from a moderate-risk condition (principally Fuchs dystrophy or pseudophakic corneal edema) underwent DSAEK by 2 experienced surgeons. The donor was folded over and inserted with single-point fixation forceps. This retrospective analysis assessed graft survival, complications, and endothelial cell loss, which was calculated from baseline donor and 6-month and 1-year postoperative central endothelial images evaluated by an independent specular microscopy reading center.
No primary graft failures occurred in either group. One-year graft survival rates were comparable (98% vs 97%) in the 5.0- and 3.2-mm groups, respectively (P = 1.0). Complications included graft dislocation, graft rejection episodes, and elevated intraocular pressure and occurred at similar rates in both groups (P > or = 0.28). Pupillary block glaucoma did not occur in either group. Mean baseline donor endothelial cell density did not differ: 2782 cells per square millimeter in the 5.0-mm (n = 64) and 2784 cells per square millimeter in the 3.2-mm (n = 103) groups. Percent endothelial cell loss was 27% +/- 20% (n = 55) versus 40% +/- 22% (n = 71; 6 months) and 31% +/- 19% (n = 45) versus 44% +/- 22% (n = 62; 12 months) in the 5.0- and 3.2-mm incision groups, respectively (both P < 0.001).
One year after DSAEK, overall graft success was comparable for the 2 groups; however, the 5.0-mm incision width resulted in substantially lower endothelial cell loss at 6 and 12 months.
评估在撕囊自动角膜内皮移植术(DSAEK)后 6 个月和 1 年时,切口宽度(5.0 和 3.2mm)对移植物存活率和内皮细胞丢失的影响。
167 例因中度风险情况(主要为 Fuchs 营养不良或白内障术后角膜水肿)导致内皮功能失代偿的患者,由 2 名经验丰富的外科医生行 DSAEK。供体折叠并用单点固定夹插入。该回顾性分析评估了移植物存活率、并发症和内皮细胞丢失情况,这是通过独立的共焦显微镜阅读中心评估的基线供体和 6 个月及 1 年术后中央内皮图像计算得出的。
两组均未发生原发性移植物失功。两组 1 年移植物存活率相当(分别为 98%和 97%,P=1.0)。两组并发症发生率相似,包括移植物脱位、移植物排斥发作和眼压升高(均 P≥0.28)。两组均未发生瞳孔阻滞性青光眼。基线供体内皮细胞密度无差异:5.0mm 组(n=64)为 2782 个/平方毫米,3.2mm 组(n=103)为 2784 个/平方毫米。6 个月时,5.0mm 组和 3.2mm 组的内皮细胞丢失率分别为 27%±20%(n=55)和 40%±22%(n=71;P<0.001),12 个月时分别为 31%±19%(n=45)和 44%±22%(n=62;P<0.001)。
DSAEK 后 1 年,两组总体移植物成功率相当;然而,5.0mm 切口宽度在 6 个月和 12 个月时导致内皮细胞丢失明显减少。